Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Venture Global LNG Raises $1.75 Billion in IPO
Venture Global trades below IPO price in disappointing debut despite Trump's support of LNG industry
"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an interview Friday.
LNG exporter Venture Global dips below IPO price in its trading debut
The energy company raised $1.75 billion by pricing 70 million shares at $25, the middle of its reduced $23 to $27 price range.
LNG exporter Venture Global raises $1.75 bln in US IPO
Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial public offering of President Donald Trump's second term as investors bet on his plan to boost U.
LNG Exporter Venture Global Stock Trades Below IPO Price in Debut
Shares of liquefied natural gas exporter Venture Global debuted Friday below their initial public offering price of $25 per share.
LNG Exporter Venture Global Shares Open 3.8% Below IPO Price
Venture Global Inc. shares slipped 3.8% in the natural gas exporter’s debut as a public company, after slashing its price target ahead of its IPO.
Venture Global LNG Raises $1.75 Billion in IPO Amid Adjusted Valuation
Venture Global LNG has successfully raised $1.75 billion through its U.S. IPO after pricing 70 million shares at $25 each. The offering was adjusted from an initial plan of 50 million shares priced at $40 to $46 to
Ascentage Pharma, IPO
Ascentage Pharma CEO Dr. Yang on IPO
Dr. Dajun Yang, Ascentage Pharma CEO, joins 'Closing Bell Overtime' to talk today's IPO. Marilyn Manson won’t face sexual assault, domestic violence charges in LA
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut after pricing its $126.4 million initial public offering at a discount to its Asian stock.
Takeda-backed Ascentage Pharma aims to raise $126 million in US IPO
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
14h
IPO market comeback: How recent major US listings fared
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
6h
Venture Global’s Stumble Reflects Chilly State of the IPO Market
Venture Global launched its initial public offering with a lofty goal: Raise up to $2.3 billion at a $110 billion valuation ...
10h
3FPX, ARM : IPO Rebound In 2025? Here's What's Fueling The Boom,...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
20h
Trump Partner Builds $1 Billion Stake From India Real Estate IPO
When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...
10h
2024 Year In Review: IPO Market Overview
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
11h
on MSN
Even Trump Couldn’t Save This Energy IPO
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
FierceBiotech
12h
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
8h
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Venture Global
Initial public offering
Trump
United States
Smithfield Foods
Feedback